Valuation : Kwality Pharmaceuticals Limited

Market Cap 3.51TCr 37Cr 32Cr 30Cr 27Cr 51Cr 52Cr 355.26Cr 138.28Cr 1.79TCr 139.05Cr 136.04Cr 5.93TCr P/E 2025
22.6x
P/E 2026 20.1x
Enterprise Value 3.64TCr 38Cr 33Cr 31Cr 28Cr 53Cr 54Cr 368.11Cr 143.28Cr 1.85TCr 144.08Cr 140.96Cr 6.14TCr EV / Sales 2025
2.7x
EV / Sales 2026 2.95x
Free-Float
22.51%
Yield 2025 *
-
Yield 2026 -
10/08 Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
02/06 Kwality Pharmaceuticals Limited Announces Resignation of Kartik Kapur as Independent Director, Effective June 02, 2026 CI
19/05 Kwality Pharmaceuticals' Consolidated Profit Rises in Fiscal Q4; Shares Jump 9% MT
19/05 Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 CI
19/05 Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
11/03 Chatha Foods Limited Announces Change in Designation of Mrs. Rachna Singh Chaudhary as Chief Human Resource Officer, Effective March 11, 2026 CI
10/03 Kwality Pharmaceuticals completes phase 1 BE studies for three molecules RE
12/02 Kwality Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q3; Shares Surge 16% MT
12/02 Kwality Pharmaceuticals Ltd Dec-quarter consol net profit 160.1 million rupees RE
12/02 Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02/02 Kwality Pharmaceuticals Limited Announces Completion of Term of Pankaj Takkar and Ravi Shanker as Independent Directors and from Committees Membership and Chairmanship, Effective January 31, 2026 CI
13/11 Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
13/11 Kwality Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q2; Shares Up 7% MT
1 day-0.99%
1 week+0.91%
Current month+2.08%
1 month+31.19%
3 months+46.21%
6 months+121.49%
Current year+202.61%
1 week 3,212.2
Extreme 3212.2
3,471
1 month 2,476
Extreme 2476
3,725.45
Current year 1,020
Extreme 1020
3,725.45
1 year 828.8
Extreme 828.8
3,725.45
3 years 308.7
Extreme 308.7
3,725.45
5 years 248
Extreme 248
3,725.45
10 years 21.3
Extreme 21.3
3,725.45
Manager TitleAgeSince
Chief Executive Officer 72 04/05/1983
Director of Finance/CFO 32 22/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 72 04/05/1983
Director/Board Member 58 01/08/1995
Director/Board Member 64 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%+0.91%+239.23%+769.14% 37Cr
+0.28%-5.97%+58.34%+108.22% 1,03400Cr
+2.01%-0.71%+53.07%+68.99% 65TCr
+1.39%-2.18%+23.57%+75.43% 46TCr
+0.53%-5.32%+33.09%+35.34% 34TCr
-0.78%+2.19%+28.42%+45.97% 31TCr
-0.82%-2.98%-0.29%+11.04% 25TCr
+1.92%-0.93%+52.28%+70.67% 24TCr
-0.20%-3.80%-18.16%-55.24% 20TCr
+2.45%+0.77%+32.71%+95.59% 19TCr
Average +0.75%-2.55%+50.23%+122.51% 36.72TCr
Weighted average by Cap. +1.17%-3.31%+38.32%+66.52%

Financials

2025 2026
Net sales 370.2Cr 3.9Cr 3.36Cr 3.17Cr 2.88Cr 5.42Cr 5.45Cr 37Cr 15Cr 188.31Cr 15Cr 14Cr 624.41Cr 503.08Cr 5.3Cr 4.57Cr 4.3Cr 3.92Cr 7.37Cr 7.41Cr 51Cr 20Cr 255.91Cr 20Cr 19Cr 848.55Cr
Net income 40Cr 41.98L 36.22L 34.07L 31.03L 58.36L 58.68L 4.03Cr 1.57Cr 20Cr 1.58Cr 1.54Cr 67Cr 67Cr 70.96L 61.21L 57.58L 52.46L 98.64L 99.17L 6.81Cr 2.65Cr 34Cr 2.66Cr 2.61Cr 113.59Cr
Net Debt 98Cr 1.03Cr 88.79L 83.52L 76.09L 1.43Cr 1.44Cr 9.87Cr 3.84Cr 50Cr 3.86Cr 3.78Cr 164.77Cr 127.11Cr 1.34Cr 1.16Cr 1.09Cr 99.01L 1.86Cr 1.87Cr 13Cr 5Cr 65Cr 5.03Cr 4.92Cr 214.4Cr
Logo Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Employees
1,137
Date Price Change Volume
02/26/02 3,404.70 +0.51% 2,102
01/26/01 ₹3,387.50 +3.10% 10,376
31/26/31 ₹3,285.80 -0.74% 1,781
28/26/28 ₹3,310.25 +1.37% 1,704
27/26/27 ₹3,265.50 -1.76% 4,200

Annual profits - Rate of surprise